Frontiers in Immunology (May 2021)

Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity

  • Miaoran Xia,
  • Miaoran Xia,
  • Miaoran Xia,
  • Miaoran Xia,
  • Bingbing Wang,
  • Bingbing Wang,
  • Bingbing Wang,
  • Bingbing Wang,
  • Zihan Wang,
  • Zihan Wang,
  • Zihan Wang,
  • Zihan Wang,
  • Xulong Zhang,
  • Xi Wang,
  • Xi Wang,
  • Xi Wang,
  • Xi Wang

DOI
https://doi.org/10.3389/fimmu.2021.672328
Journal volume & issue
Vol. 12

Abstract

Read online

Natural killer (NK) cells are critical innate lymphocytes that can directly kill target cells without prior immunization. NK cell activation is controlled by the balance of multiple germline-encoded activating and inhibitory receptors. NK cells are a heterogeneous and plastic population displaying a broad spectrum of functional states (resting, activating, memory, repressed, and exhausted). In this review, we present an overview of the epigenetic regulation of NK cell-mediated antitumor immunity, including DNA methylation, histone modification, transcription factor changes, and microRNA expression. NK cell-based immunotherapy has been recognized as a promising strategy to treat cancer. Since epigenetic alterations are reversible and druggable, these studies will help identify new ways to enhance NK cell-mediated antitumor cytotoxicity by targeting intrinsic epigenetic regulators alone or in combination with other strategies.

Keywords